1-(4'-Hydroxy-[1,1'-biphenyl]-4-yl)ethanone, 97%, 250mg

2-Bromo-3,6-difluoroanisole, 97.0%, 250mg

ETHYL 4-HYDROXYBUTANOATE, 95%, 25g

1,1,1,3,3,3-Hexamethyldisilazane>96.0%(GC)500mL

Bioculaire iScope IS.1158-PLPHi pour contraste de phase avec objectifs Plan phase IOS et platine croisée sans rack (infini - tête inclinable ergonomique)

tert-Butyl (S)-(oxiran-2-ylmethyl)carbamate, 97%, 1g

8-FLUOROQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 5g

4-Bromobenzimidamide, 95.0%, 25g

5-Bromo-1-ethoxy-2-fluoro-3-methylbenzene, 98%, 1g

2,4,6-Triphenyl-1,3,5,2,4,6-trioxatriborinane, 95.0%, 25g

2-(azidomethyl)naphthalene, 95.0%, 2.5g

2-Amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97.0%, 5g

2-methyl-6-[(piperidin-4-yl)methoxy]pyridine dihydrochloride, 95.0%, 250mg